Press Releases
Hogan Lovells boosts Paris practice with leading hires to its Corporate Practice
13 January 2021
Matthieu Grollemund
PartnerParis
Email matthieu.grollemund@hoganlovells.com
Phone +33 1 53 67 47 47
LanguagesEnglish, French, German
Practice groupCorporate & Finance
"He is very business-oriented and a deal-maker"
Chambers Europe 2020
Matthieu Grollemund is a Corporate partner in our Paris office and a member of our global Private Equity leadership team.
Triple qualified in French, US and UK law, he is a seasoned corporate lawyer active in complex and cross-border transactions. He advises private equity funds, companies, board of directors and senior managers in their most sensitive M&A transactions, IPOs, privately negotiated or hostile transactions involving public or private companies. He is particularly known in the Tech and Healthcare industries.
Prior to joining the firm, Matthieu Grollemund was Co-Head of the Paris Corporate Department of an international law firm. He also spent five years as a partner in a US-based global law firm in the New York office.
Awards and recognitions
2021
Corporate/M&A (France), Foreign Expert for USA
Chambers Global
2020-2021
Lawyers specialised in LBOs (transactions on companies worth more than €300m) and innovation capital
Option Droit & Affaires
2020
Ranked Individuals “Private Equity: Venture Capital in France”
Chambers Europe
2017
Foreign Expert in Corporate/M&A (France and UK)
Chambers Global
2016
Most Innovative Lawyers in Europe
Financial Times
Education and admissions
Education
Corporate Law, University of Paris I Panthéon-Sorbonne, 1997
M.B.A., ESCP Paris, 1995
Bar admissions and qualifications
Paris
Solicitor, England and Wales
Licensed as a Foreign Legal Consultant, New York
Representative experience
Advised on a number of major tech transactions (Blablacar, Criteo, Doctolib, Mirakl, Ynsect, Ledger, Contentsquare, ManoMano, FarFetch, Exotec)*
Advised on a number of French and international IPO and offerings (AAA, Criteo, Navya, Farfetch)*
Advised on a number of public tender of offers (Zimmer Biomet on Medtech, Medtronic on Medicrea)*
Advised on the acquisition by Arch of a 30% block in Coface*
Advised Tencent on the acquisition of a minority interest in Ubisoft from Vivendi*
Advised ADM in the acquisition of Neovia from Invivo and Eurazeo for €1.4bn*
Advised in the disposition of Maesa to Bain capital*
Routinely advises a number of private equity funds on their growth and LBO investments mostly in the Tech, Life Science, Fintech and highly regulated industries*
*Matter handled prior to joining Hogan Lovells.
